262 related articles for article (PubMed ID: 29778772)
1. Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016.
Meyerson BE; Agley JD; Davis A; Jayawardene W; Hoss A; Shannon DJ; Ryder PT; Ritchie K; Gassman R
Drug Alcohol Depend; 2018 Jul; 188():187-192. PubMed ID: 29778772
[TBL] [Abstract][Full Text] [Related]
2. Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order.
Eldridge LA; Agley J; Meyerson BE
J Am Pharm Assoc (2003); 2020; 60(3):470-474. PubMed ID: 31917248
[TBL] [Abstract][Full Text] [Related]
3. Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.
Sisson ML; McMahan KB; Chichester KR; Galbraith JW; Cropsey KL
Int J Drug Policy; 2019 Dec; 74():229-235. PubMed ID: 31698165
[TBL] [Abstract][Full Text] [Related]
4. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order.
Santa HM; Amirova SG; Ventricelli DJ; Downs GE; Nowalk AA; Pringle JL; Aruru M
Am J Health Syst Pharm; 2021 Feb; 78(4):327-335. PubMed ID: 33336254
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with naloxone availability and dispensing through Michigan's pharmacy standing order.
Dahlem CH; Myers M; Goldstick J; Stevenson JG; Gray G; Rockhill S; Dora-Laskey A; Kellenberg J; Brummett CM; Kocher KE
Am J Drug Alcohol Abuse; 2022 Jul; 48(4):454-463. PubMed ID: 35405078
[No Abstract] [Full Text] [Related]
6. Pharmacist counseling when dispensing naloxone by standing order: A secret shopper study of 4 chain pharmacies.
Contreras J; Baus C; Brandt C; Witry M; Peters J; Evoy KE
J Am Pharm Assoc (2003); 2021; 61(2):e94-e99. PubMed ID: 33153912
[TBL] [Abstract][Full Text] [Related]
7. Naloxone Availability and Pharmacy Staff Knowledge of Standing Order for Naloxone in Pennsylvania Pharmacies.
Graves RL; Andreyeva E; Perrone J; Shofer FS; Merchant RM; Meisel ZF
J Addict Med; 2019; 13(4):272-278. PubMed ID: 30585876
[TBL] [Abstract][Full Text] [Related]
8. Pharmacists and Naloxone: Barriers to Dispensing and Effectiveness of an Educational Outreach Program.
Hanson KA; Smart MH; Mandava MR; Carkovic E; Aslamy M; Lee TA; Pickard AS
J Am Pharm Assoc (2003); 2023; 63(2):608-613.e3. PubMed ID: 36631342
[TBL] [Abstract][Full Text] [Related]
9. Pharmacists' experiences with a statewide naloxone standing order program in Massachusetts: a mixed methods study.
Pollini RA; Slocum S; Ozga J; Joyce R; Xuan Z; Green TC; Walley AY
J Am Pharm Assoc (2003); 2022; 62(1):157-166. PubMed ID: 34511372
[TBL] [Abstract][Full Text] [Related]
10. Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina.
Rudolph SE; Branham AR; Rhodes LA; Hayes HH; Moose JS; Marciniak MW
J Am Pharm Assoc (2003); 2018; 58(4S):S55-S58.e3. PubMed ID: 30006187
[TBL] [Abstract][Full Text] [Related]
11. Predicting pharmacy syringe sales to people who inject drugs: Policy, practice and perceptions.
Meyerson BE; Davis A; Agley JD; Shannon DJ; Lawrence CA; Ryder PT; Ritchie K; Gassman R
Int J Drug Policy; 2018 Jun; 56():46-53. PubMed ID: 29558701
[TBL] [Abstract][Full Text] [Related]
12. Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.
Melaragni F; Levy C; Pedrazzi J; Andersen M
J Am Pharm Assoc (2003); 2019; 59(4):550-554.e2. PubMed ID: 31109812
[TBL] [Abstract][Full Text] [Related]
13. Pharmacists' readiness to provide naloxone in community pharmacies in West Virginia.
Thornton JD; Lyvers E; Scott VGG; Dwibedi N
J Am Pharm Assoc (2003); 2017; 57(2S):S12-S18.e4. PubMed ID: 28163027
[TBL] [Abstract][Full Text] [Related]
14. Community pharmacists in Virginia dispensing naloxone under a standing order: A qualitative study.
Ijioma SC; Fernández EV; Gatewood SB; Carroll NV; Salgado TM
J Am Pharm Assoc (2003); 2021; 61(6):753-760.e1. PubMed ID: 34229945
[TBL] [Abstract][Full Text] [Related]
15. Naloxone Availability in Retail Pharmacies and Neighborhood Inequities in Access.
Egan KL; Foster SE; Knudsen AN; Lee JGL
Am J Prev Med; 2020 May; 58(5):699-702. PubMed ID: 32005590
[TBL] [Abstract][Full Text] [Related]
16. Availability of Naloxone in Pharmacies and Knowledge of Pharmacy Staff Regarding Dispensing Naloxone to Younger Adolescents.
Jimenez DE; Singer MR; Adesman A
J Adolesc Health; 2019 Nov; 65(5):698-701. PubMed ID: 31540779
[TBL] [Abstract][Full Text] [Related]
17. Pharmacy naloxone codispensing: A mixed methods study of practices and perspectives under a statewide standing order program.
Pollini RA; Slocum S; Ozga JE; Joyce R; Xuan Z; Green TC; Walley AY
J Am Pharm Assoc (2003); 2022; 62(5):1546-1554. PubMed ID: 35450833
[TBL] [Abstract][Full Text] [Related]
18. Access to naloxone at community pharmacies under the Massachusetts statewide standing order.
Wu C; Brown T; Moreno JL
J Am Pharm Assoc (2003); 2020; 60(4):647-652. PubMed ID: 31843374
[TBL] [Abstract][Full Text] [Related]
19. Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study.
Burstein D; Baird J; Bratberg J; Donovan E; Soipe A; Tapper A; Case P; Walley AY; Green TC
J Am Pharm Assoc (2003); 2020; 60(2):304-310. PubMed ID: 31870862
[TBL] [Abstract][Full Text] [Related]
20. Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing.
Freeman PR; Goodin A; Troske S; Strahl A; Fallin A; Green TC
J Am Pharm Assoc (2003); 2017; 57(2S):S28-S33. PubMed ID: 28139459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
